Medtech Insight is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
MAKO Surgical gets $40mm via private placement; could add $20mm
06 Nov 2008
MAKO Surgical (implants for minimally invasive orthopedic procedures) announced a private placement that could bring in $60mm. The company initially grossed $40mm through the sale of 6.45mm common shares at $6.20 each (a 9% discount) to lead and first-time investors Montreux Equity Partners and Skyline Ventures, which each add a representative to the board. Other new backer Alta Partners was joined by returning shareholders Ziegler Meditech Equity Partners, MK Investment Company, Lumira Capital, Aperture Venture Partners, and two company board members. MAKO also issued seven-year warrants to buy another 1.29mm shares exercisable at $7.44. The company could bring in another $20mm by the end of 2009 if certain milestones are met.
Surgical Equipment & Devices
Minimally or Less Invasive
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?